1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA SMARCA5 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA PPP4R3A CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA FXYD6 CTRPv2 pan-cancer AAC 0.14 2e-05
mRNA GMIP CTRPv2 pan-cancer AAC 0.18 2e-05
mRNA BEST1 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA C15orf38-AP3S2 CTRPv2 pan-cancer AAC -0.15 2e-05
mRNA KCNS1 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA MAU2 CTRPv2 pan-cancer AAC 0.15 2e-05
mRNA POLD4 CTRPv2 pan-cancer AAC -0.14 2e-05
mRNA PRRC2B CTRPv2 pan-cancer AAC 0.14 2e-05
Download CSV